Stay updated on Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial
Sign up to get notified when there's something new on the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page.

Latest updates to the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page
- Check5 days agoChange DetectedThe new screenshot shows minor formatting changes on the Study Details page; no changes to core content such as eligibility criteria, locations, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check33 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check41 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check55 days agoChange DetectedVersion updated to v3.0.2 and 'Back to Top' removed; no significant changes to core content or availability.SummaryDifference0.3%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and drug information for Efgartigimod Alfa, while removing specific location details and an earlier revision number.SummaryDifference2%

Stay in the know with updates to Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page.